Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Multiorgan-on-a-chip (multi-OoC) devices, by supporting cross-organ communication, allow the study of multiorgan processes and modeling of systemic diseases. Multi-OoC approaches provide new insights that would be lost using single-OoC models.
The global Multiorgan-on-a-Chip market was valued at US$ 151 million in 2023 and is anticipated to reach US$ 294.1 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
Multi-organ chip is an advanced biomedical technology, also known as "human organ simulation chip" or "in vitro organ chip". It is used to simulate the structure and function of multiple human organs, and realize the interaction between these organs on the chip. It is the product of the combination of microfluidic chip technology and cell culture technology, aiming to more realistically simulate the complex functions and interrelationships of human organs. Although traditional cell culture and animal experiments are helpful to study the biological characteristics of a single organ, they cannot simulate the interaction between organs and the complex physiological processes in vivo. The emergence of multi-organ chips solves this problem. It can simulate multiple organs on a tiny chip, such as liver, kidney, heart, lung, etc., while simulating blood circulation and signal communication between organs.
This report aims to provide a comprehensive presentation of the global market for Multiorgan-on-a-Chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiorgan-on-a-Chip.
Report Scope
The Multiorgan-on-a-Chip market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiorgan-on-a-Chip market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiorgan-on-a-Chip manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CN Bio Innovations
Mimetas
Hesperos
TissUse
Emulate
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Segment by Type
Heart-Liver Two-Organ Model
Heart-Liver-Cancer Three Organ Model
Neuromuscular Junction (NMJ) Two-Organ Model
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Multiorgan-on-a-Chip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Multiorgan-on-a-Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Multiorgan-on-a-Chip market was valued at US$ 151 million in 2023 and is anticipated to reach US$ 294.1 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
Multi-organ chip is an advanced biomedical technology, also known as "human organ simulation chip" or "in vitro organ chip". It is used to simulate the structure and function of multiple human organs, and realize the interaction between these organs on the chip. It is the product of the combination of microfluidic chip technology and cell culture technology, aiming to more realistically simulate the complex functions and interrelationships of human organs. Although traditional cell culture and animal experiments are helpful to study the biological characteristics of a single organ, they cannot simulate the interaction between organs and the complex physiological processes in vivo. The emergence of multi-organ chips solves this problem. It can simulate multiple organs on a tiny chip, such as liver, kidney, heart, lung, etc., while simulating blood circulation and signal communication between organs.
This report aims to provide a comprehensive presentation of the global market for Multiorgan-on-a-Chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiorgan-on-a-Chip.
Report Scope
The Multiorgan-on-a-Chip market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiorgan-on-a-Chip market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiorgan-on-a-Chip manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CN Bio Innovations
Mimetas
Hesperos
TissUse
Emulate
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Segment by Type
Heart-Liver Two-Organ Model
Heart-Liver-Cancer Three Organ Model
Neuromuscular Junction (NMJ) Two-Organ Model
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Multiorgan-on-a-Chip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Multiorgan-on-a-Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
